A multidisciplinary panel of experts has issued guidelines that consolidate current evidence on testing for molecular biomarkers in colorectal cancer. The guidelines aim to standardize molecular testing for patients with colorectal cancer and help clinicians identify patients most likely to benefit from targeted treatments.
No takes yet. Share an insight, caveat, or question.
A 2017 study studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: